Cargando…
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641957/ https://www.ncbi.nlm.nih.gov/pubmed/34901883 http://dx.doi.org/10.1016/S2665-9913(21)00392-1 |
_version_ | 1784609590400253952 |
---|---|
author | Gao, Xing-Su Zhu, Feng-Cai |
author_facet | Gao, Xing-Su Zhu, Feng-Cai |
author_sort | Gao, Xing-Su |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8641957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86419572021-12-06 Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease Gao, Xing-Su Zhu, Feng-Cai Lancet Rheumatol Comment Elsevier Ltd. 2022-02 2021-12-03 /pmc/articles/PMC8641957/ /pubmed/34901883 http://dx.doi.org/10.1016/S2665-9913(21)00392-1 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Gao, Xing-Su Zhu, Feng-Cai Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title | Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title_full | Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title_fullStr | Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title_full_unstemmed | Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title_short | Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease |
title_sort | distinct immune response to coronavac in sars-cov-2 seropositive and seronegative patients with autoimmune rheumatic disease |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641957/ https://www.ncbi.nlm.nih.gov/pubmed/34901883 http://dx.doi.org/10.1016/S2665-9913(21)00392-1 |
work_keys_str_mv | AT gaoxingsu distinctimmuneresponsetocoronavacinsarscov2seropositiveandseronegativepatientswithautoimmunerheumaticdisease AT zhufengcai distinctimmuneresponsetocoronavacinsarscov2seropositiveandseronegativepatientswithautoimmunerheumaticdisease |